<DOC>
	<DOCNO>NCT01848093</DOCNO>
	<brief_summary>chronic obstructive pulmonary disease ( COPD ) typically associate mucus hypersecretion airway . In health , mucin major macromolecular component responsible protective clearance property mucus gel . In recent study investigator find mucin decrease unstable sputum adult cystic fibrosis ( CF ) patient . In study investigator want investigate difference mucin quantity quality airway secretion pulmonary exacerbation patient COPD .</brief_summary>
	<brief_title>Mucin Concentration Sputum From COPD Patients During Pulmonary Exacerbation</brief_title>
	<detailed_description>We hypothesize exacerbation mucin amount increase . The aim study evaluate molecular ( mucin ) structure property ( mucin-stability ) airway secretion COPD related severity disease . We characterize sputum composition patient pulmonary exacerbation . Using gel electrophoresis , specific antibody analyze MUC5AC MUC5B mucin . The significance study give u novel information pathogenesis chronic inflammatory airway disease , provide tool assess progression lung disease , critically , identify novel opportunity target therapeutic intervention .</detailed_description>
	<criteria>forced expiratory volume one second ( FEV1 ) &lt; 80 % sputum production clinical likely hood exacerbation FEV1 &gt; 80 % &lt; 30 % increased systemic inflammation susceptibility pneumonia need antibiotic treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>lung</keyword>
	<keyword>airway</keyword>
	<keyword>pulmonary exacerbation</keyword>
	<keyword>mucus</keyword>
</DOC>